Skip to main content

 ANC: Neuroscience of Disease

Editors-in-Chief

Jeroen Hoozemans, Amsterdam University Medical Centers, The Netherlands
Jason Huse, University of Texas MD Anderson Cancer Center, USA

Aims and scope

Acta Neuropathologica Communications (ANC) focuses on the pathogenesis of neurological disease using experimental or human tissues, molecular, cellular, biological and morphological techniques

Call for Papers: Investigating the Biology of Brain Metastases


This Collection aims to bring together the latest research on brain metastases biology.
 

Read More

Call for Papers: Neuropathology and Neurodegeneration in the Retina


This Collection will highlight basic, translational, and clinical studies that address current knowledge gaps in retinal neurodegenerations.
 

Read More

Why publish with ANC?

  • No major revisions: only minor revisions are requested that can be performed (and have to be performed) within 3 weeks
  • Fast, thorough peer review: group of editors selected on the basis of their insightful, dedicated and prompt service
  • Rapid publication: publication within 2 months of submission
  • Inclusion in all major indexing services, such as PubMed, MEDLINE and Web of Science
  • Open access: enabling it to be read by a much larger set of readers, increasing its visibility
  • Competitive APC: flat article-processing charge, with no page limits, color figure charges or submission fees

Articles

Our Commitment to excellent author service

ANC is committed to rapid publication. We aim to publish all research articles within 2 months of submission, subject to authors responding to requests within the required timeframe. For further information, please read our FAQs or contact jjm.hoozemans@amsterdamumc.nl.

Sister journal

ANC is sister journal to Acta Neuropathologica, a journal dedicated to the pathology and mechanisms of neurological disease.

Read more here


From the Editors-in-Chief

"The unique combination of human neuropathology with relevant experimental models is essential for understanding the pathogenesis of neurological diseases. Acta Neuropathologica Communications provides a platform for studies that centrally involve human neuropathology and bring new insight in disease mechanisms of neurological diseases using relevant experimental models. We welcome high quality papers that do not require major revisions, resulting in short turn-around times and fast publication. We hope you enjoy Acta Neuropathologica Communications and are looking forward to receive your submissions."

Jeroen Hoozemans, co-Editor-in-Chief, ANC

"As an original member of the ANC editorial board, it has been a pleasure to witness the growth and maturation of this journal first hand.  ANC now occupies a well-defined niche for the rapid publication of high-quality work advancing the broad spectrum of neuropathology and its allied sciences. I look forward to receiving and evaluating your compelling manuscripts in the months and years ahead." 

Jason T. Huse, co-Editor-in-Chief, ANC

Annual Journal Metrics

  • 2022 Citation Impact
    7.1 - 2-year Impact Factor
    7.8 - 5-year Impact Factor
    1.289 - SNIP (Source Normalized Impact per Paper)
    2.395 - SJR (SCImago Journal Rank)

    2023 Speed
    3 days submission to first editorial decision for all manuscripts (Median)
    50 days submission to accept (Median)

    2023 Usage
    1,631,164 downloads
    3,652 Altmetric mentions